PTK2 and cancer: Compound 22 suppressed FAK activity (IC50 = 28.2 nM) and inhibited U-87MG (IC50 = 0.16 μM), A-549 (IC50 = 0.27 μM) and MDA-MB-231(IC50 = 0.19 μM) cancer cell line proliferation.